This is paralleled with observed decreases in immune suppressive components of the TME, such as TGFβ and infiltrated MDSCs and M2 macrophages, and increased macrophage polarization to an M1 phenotype, which are collectively supportive of tumor control (36, 55). The gene discussed is TGFB1; the disease is neoplasm.